Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition

Medical Mycology

Volumn 47, Issue 7, 2009, Pages 681-689

  Silva, Snia ^a   Henriques, Mariana ^a   Martins, Antnio ^a   Oliveira, Rosrio ^a   Williams, David ^b   Azeredo, Joana ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Biofilm; Non Candida albicans Candida species

Indexed keywords

CARBOHYDRATE; CRYSTAL VIOLET; PROTEIN;

ARTICLE; BIOFILM; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CARBOHYDRATE ANALYSIS; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FUNGAL STRAIN; FUNGUS ISOLATION; MORPHOLOGICAL TRAIT; NONHUMAN; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY; SPECIES; SPECIES DIFFERENTIATION; STAINING;

BIOFILMS; CANDIDA; CANDIDIASIS; CARBOHYDRATES; FEMALE; FUNGAL PROTEINS; HUMANS; MOUTH; URINARY TRACT; VAGINA;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 70349990092     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780802549594     Document Type: Article

References (41)

1. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 449-511.
2. Odds FC. Candida and Candidosis, 2nd edn. London : Bailliere Tindall, 1998.
3. Samaranayake LP, Fidel PL, Naglik JR, e t al. Fungal infections associated with HIV infection. Oral Dis 2002; 8: 151-160.
4. Fanello S, Bouchara JP, Jousset N, Delbos V, LeFlohic AM. Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. J Hosp Infect 2001; 47: 46-52.
5. Hargety JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt). 2003; 4: 263-271.
6. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267.
7. Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002; 5: 608-611.
8. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Amer J Clin Pathol 1980; 73: 518-521.
9. Bassetti M, Righi E, Costa A, e t al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 6: 21.
10. Weinberger M, Leibovici L, Perez S, et al. Characteristics of candidaemia with Candida albicans compared with non albicans Candida species and predictors of mortality. J Hosp Infect 2005; 61: 146-154.
11. Nucci M, Colombo AL. Candidemia due to Candida tropicalis : clinical, epidemiologic and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007; 58: 77-82.
12. Rho J, Shin JH, Song JW, e t al. Molecular investigation of two consecutive nosocomial clusters of Candida tropicalis candiduria using pulsed-fi eld gel electrophoresis. J Microbiol 2004; 42: 80-86.
13. Bonassoli LA, Bertoli M, Svidzinski TIE. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect 2005; 59: 159-162.
14. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519-1527.
15. Tsai H, Bobek LA. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azolesensitive and -resistant Candida species. Antimicrob Agents Chemother 1997; 41: 2224-2228.
16. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbial 1995; 49: 711-745.
17. Donlan RM, Costerton JW. biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
18. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46: 397-403.
19. Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Update 2004; 7: 301-309.
20. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimcrob Agents Chemother 1995; 39: 2128-2131.
21. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilm. J Med Microbiol 1999; 48: 671-679.
22. Chandra J, Kuhn DM, Mukherjee PK, et al. biofilm formation by the fungal pathogen Candida albicans : development, architecture and drug resistance. J Bacteriol 2001; 183: 5385-5394.
23. Jin Y, Yip KH, Samaranayake YH, Yau JY, Samaranayake LP. biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodefi ciency virus infection. J Clin Microbiol 2003; 41: 2961-2967.
24. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically signifi cant problem. FEMS Yeast Res 2006; 6: 979-986.
25. Hawser SP, Douglas LJ. biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994; 62: 915-921.
26. Shin JH, Kee SJ, Shin MG, e t al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40: 1244-1248.
27. Samaranayake YH, Ye J, Yau JYY, Cheung BPK, Samaranayake LP. In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 2005; 43: 818-825.
28. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis : chemical composition and role in drug resistance. J Med Microbiol 2006; 55: 999-1008.
29. Jain N, Kohli R, Cook E, et al. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007; 73: 1693-1703.
30. Bizerra CF, Nakamura CV, Poersch C, e t al. Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res 2008; 8: 442-450.
31. Scherer S, Stevens DA. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol 1987; 25: 675-679.
32. Azeredo J, Henriques M, Sillankorva S, Oliveira R. Extraction of exopolymers from biofilms: the protective effect of glutaraldehyde. Water Sci Technol 2003; 47: 175-179.
33. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-356.
34. Parahitiyawa NB, Samaranayake YH, Samaranayake LP, e t al. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2006; 114: 298-306.
35. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002; 70: 878-888.
36. Zaw MT, Samaranayake YH, Samaranayake LP. I n vitro biofilm formation of Candida albicans and non- albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol 2007; 52: 761-767.
37. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002; 46: 3634-3636.
38. Wimpenny J, Manz W, Szewzyk U. Heterogeneity in biofilms. F EMS Microbiol Rev 2000; 24: 661-671.
39. Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother. 2004; 48: 3291-3297.
40. Kcrmery K Jr. Torulopsis glabrata an emerging pathogen in cancer patients. Int J Antimicrob Agents 1999; 11: 1-6.
41. Kumar CPG, Menon T. Biofilm production by clinical isolates of Candida species. Med Mycol 2006; 44: 99-101.